Suppr超能文献

短期热量限制对2型糖尿病患者体重减轻及血糖控制的影响。

The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes.

作者信息

Williams K V, Mullen M L, Kelley D E, Wing R R

机构信息

Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania, USA. kvw+@.pitt.edu

出版信息

Diabetes Care. 1998 Jan;21(1):2-8. doi: 10.2337/diacare.21.1.2.

Abstract

OBJECTIVE

To determine whether an intermittent very-low-calorie diet (VLCD) improves weight loss and glycemic control more than moderate caloric restriction alone.

RESEARCH DESIGN AND METHODS

Individuals with type 2 diabetes (n = 54) who were > or = 20% over ideal body weight participated in a 20-week behavioral weight control program. Subjects were randomized to either a standard behavioral therapy (SBT) group or to one of two VLCD groups. SBT subjects received a 1,500-1,800 kcal/day diet throughout. Both VLCD groups followed a VLCD for 5 consecutive days during week 2, followed by either intermittent VLCD therapy for 1 day/week for 15 weeks (1-day) or for 5 consecutive days every 5 weeks (5-day), with a 1,500-1,800 kcal/day diet at other times.

RESULTS

Both VLCD groups lost more weight than the SBT group over the 20 weeks (P = 0.04). Although the groups did not differ in fasting plasma glucose (FPG) changes at 20 weeks, more subjects in the 5-day group attained a normal HbA1c when compared with the SBT group (P = 0.04). This benefit was independent of the effects of weight loss. The best predictor of overall change in FPG and HbA1c was the FPG response during the first 3 weeks of the program.

CONCLUSIONS

Periodic VLCDs improved weight loss in diabetic subjects. A regimen with intermittent 5-day VLCD therapy seemed particularly promising, because more subjects in this group attained a normal HbA1c. Moreover, the glucose response to a 3-week period of diet therapy predicted glycemic response at 20 weeks, and it was a better predictor of the 20-week response than initial or overall weight loss.

摘要

目的

确定间歇性极低热量饮食(VLCD)相比单纯适度热量限制在促进体重减轻和控制血糖方面是否更具优势。

研究设计与方法

54名体重超过理想体重20%或更多的2型糖尿病患者参与了一项为期20周的行为体重控制计划。受试者被随机分为标准行为疗法(SBT)组或两个VLCD组之一。SBT组受试者全程接受1500 - 1800千卡/天的饮食。两个VLCD组在第2周均连续5天采用VLCD,随后15周内,一组为每周1天的间歇性VLCD疗法(1天组),另一组为每5周连续5天的VLCD疗法(5天组),其他时间采用1500 - 1800千卡/天的饮食。

结果

在20周内,两个VLCD组的体重减轻均多于SBT组(P = 0.04)。虽然20周时各组空腹血糖(FPG)变化无差异,但与SBT组相比,5天组更多受试者的糖化血红蛋白(HbA1c)达到正常水平(P = 0.04)。这一益处独立于体重减轻的影响。FPG和HbA1c总体变化的最佳预测指标是计划前3周的FPG反应。

结论

周期性VLCD可改善糖尿病患者的体重减轻情况。间歇性5天VLCD疗法方案似乎特别有前景,因为该组更多受试者的HbA1c达到正常水平。此外,饮食疗法3周期间的血糖反应可预测20周时的血糖反应,且相较于初始或总体体重减轻情况,它是20周反应更好的预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验